Wenyan Shen Ph.D.
Vice President of Biologics and CMC,NGM Biopharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 2 different industries.|
Dr. Wenyan Shen, also known as David, Ph.D. serves as Vice President of Biologics and CMC at NGM Biopharmaceuticals, Inc. Dr. Shen is a leading expert with nearly 20 years of experience in the antibody and therapeutic protein field and has a proven record of advancing pipelines from discovery to proof-of-concept in clinical stage to registration. Dr. Shen served as Vice President and Global Head of Biologics Development at TEVA Pharmaceuticals and managed the innovative ...
630 Gateway BoulevardPhone: 650-243-5555
South San Francisco, California 94080-7014
Board Members Memberships*There is no Board Members Memberships data available.
University of Toronto
Whitehead Institute For Bio-Medical Research
East China University of Science and Technology
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|There is no Competitor Compensation data available.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.